Toxoplasma gondii inhibits apoptosis in infected cells by caspase inactivation and NF-kappaB activation.
Our experiments aimed to clarify the mechanism by which host cell apoptosis is inhibited by infection with the intracellular protozoan parasite, Toxoplasma gondii (T. gondii). Mouse spleen cells were cultured in 6-well plates with RPMI 1640/ 10% FBS at 37?, in a 5% CO2 atmosphere. Apoptosis of spleen cells was induced by actinomycin-D (AD) treatment for 1 h prior to infection with T. gondii. A variety of assays were used to assess the progression of apoptosis: DNA size analysis on agarose gel electrophoresis, flow cytometry with annexin V/PI staining, and analysis of expression levels of Bcl-2 family and NF-kappaB mRNA and proteins by RT-PCR, Western blotting, and EMSA. Additionally, transmission electron microscopy (TEM) was performed to observe changes in cell morphology. Fragmentation of DNA was inhibited in spleen cells treated with AD and T. gondii 5 h and 18 h post infection, respectively, and flow cytometry studies showed a decreased apoptotic rates in AD and T. gondii treated spleen cells. We observed decreased expression of Bax mRNA and protein, while levels of Bcl-2 mRNA remained constant in spleen cells treated with AD and T. gondii. Caspase 3 and PARP were inactivated in cells treated with AD and T. gondii, and increased levels of cleaved caspase 8 were also observed. Analysis of EMSA and Western blot data suggests that activation of transcription factor NF-kappaB may be involved in the blockade of apoptosis by T. gondii. TEM analysis showed nuclear fragmentation and chromatin condensation occurring in spleen cells treated with AD; however, such apoptosis- associated morphological changes were not observed in cells treated with both AD and T. gondii tachyzoites. Together, these data show that T. gondii infection inhibits AD induced apoptosis via caspase inactivation and NF-kappaB activation in mouse spleen cells.
Kim
Ji-Young
JY
Department of Parasitology, Institute of Biomedical Science, Hanyang University College of Medicine, Seoul, Korea.
Ahn
Myoung-Hee
MH
Jun
Hye-Sun
HS
Jung
Jai-Won
JW
Ryu
Jae-Sook
JS
Min
Duk-Young
DY
D000818:Animals; D017209:Apoptosis / Q000502:physiology*; D061945:Caspase Inhibitors; D002478:Cells, Cultured; D053938:DNA Fragmentation; D005434:Flow Cytometry; D005786:Gene Expression Regulation; D051379:Mice; D016328:NF-kappa B / Q000378:metabolism*; D000067856:Poly(ADP-ribose) Polymerase Inhibitors; D012333:RNA, Messenger / Q000378:metabolism; D014122:Toxoplasma / Q000502:physiology*; D051028:bcl-2-Associated X Protein / Q000378:metabolism
C494827:Bax protein, mouse; D061945:Caspase Inhibitors; D016328:NF-kappa B; D000067856:Poly(ADP-ribose) Polymerase Inhibitors; D012333:RNA, Messenger; D051028:bcl-2-Associated X Protein